Ensign Peak Advisors, Inc

Position in TVTX — Travere Therapeutics, Inc.

CIK 1454984 SALT LAKE CITY, UT

Position in TVTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$33,621,010

+$12,357,356 QoQ

Shares Held

591,815

-17.3% QoQ

Ownership

0.628%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#35

of 317 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. TVTX ranks #7 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	210,483	$104,553,220
2	INSM	INSMED Inc	702,951	$74,948,635
3	ABVX	Abivax S.A.	504,471	$67,225,805
4	BBIO	BridgeBio Pharma, Inc.	760,977	$56,677,566
5	ARGX	Argenx SE	52,027	$48,269,089
6	PTCT	Ptc Therapeutics, Inc.	508,056	$41,442,127
7	TVTX	Travere Therapeutics, Inc. This page	591,815	$33,621,010
8	SRRK	Scholar Rock Holding Corp	579,052	$31,847,860

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$33,621,010	591,815	-17.3%	Shares	Sole	2026-08-14
2026-03-31	$21,263,654	715,707	-11.1%	Shares	Sole	2026-05-13
2025-12-31	$30,767,265	805,215	-5.5%	Shares	Sole	2026-02-12
2025-09-30	$20,367,627	852,202	-0.8%	Shares	Sole	2025-11-13
2025-06-30	$12,710,743	858,834	+72.2%	Shares	Sole	2025-08-12
2025-03-31	$8,937,313	498,734	+353.0%	Shares	Sole	2025-05-14
2023-06-30	$1,690,951	110,088	0.0%	Shares	Sole	2023-08-14
2023-03-31	$2,475,879	110,088	+42.5%	Shares	Sole	2023-05-15
2022-12-31	$1,624,146	77,230	-20.7%	Shares	Sole	2023-02-13
2022-09-30	$2,398,211	97,330	+26.6%	Shares	Sole	2022-11-14
2022-06-30	$1,863,262	76,899	+594.0%	Shares	Sole	2022-08-12
2022-03-31	$285,531	11,080	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.